{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:43:17Z","timestamp":1781743397862,"version":"3.54.5"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p\/>\n               <jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>In upper-income countries, infants undergo low-risk ventricular septal defect (VSD) repair. Children in low- and middle-income countries frequently present at older ages with elevated pulmonary vascular resistance (PVR) and pulmonary arterial hypertension (PAH). Expensive interventions for pulmonary hypertensive crisis are not available, and children are often denied an operation due to the mortality risk. We report our early and late experiences with these patients who underwent VSD closure by traditional patch (TP) or double patch (DP) techniques.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We extracted data from patients with VSD and PAH who underwent VSD closure operations from 1996 to 2016. Information regarding cardiac catheterizations, operations, time in the intensive care unit and follow-up information was found. We identified 129 children and analysed the differences between the TP (89\/129) and the DP (40\/129) in unidirectional groups. After 2005, the patients were pretreated with sildenafil 3\u2009months before catheterization.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The TP group was younger (P \u2009&amp;lt;\u20090.001). Hospital mortality (2.5%, DP; 10.1%,TP) was not significantly different (P \u2009=\u20090.17) between the 2 groups despite significant differences in baseline PVR, PVR\/systemic vascular resistance and the number of children with a saturation less than 90%. The long-term survival and regression of PAH were better in the DP group (survival over 97% vs 93% in the TP group). Moreover, 61% of children with DP and 75% of those with TP had normal to mild elevations in pulmonary artery pressures at the last follow-up examination (P \u2009=\u20090.046).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>The DP operation is a low-risk procedure. Moreover, the long-term outcome with the use of this technique in high-risk patients with VSD and high PVR and PAH is favourable with respect to survival and showed a decrease in PAH at the last follow-up.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejcts\/ezac347","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T13:36:22Z","timestamp":1656509782000},"source":"Crossref","is-referenced-by-count":11,"title":["Early and long-term results of ventricular septal defect repair in children with severe pulmonary hypertension and elevated pulmonary vascular resistance by the double or traditional patch technique"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6002-3325","authenticated-orcid":false,"given":"Oleksandr","family":"Golovenko","sequence":"first","affiliation":[{"name":"Congenital heart surgery, Amosov National Institute of Cardiovascular Surgery , Kyiv, Ukraine"},{"name":"William Novick Global Cardiac Alliance , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasyl","family":"Lazorhyshynets","sequence":"additional","affiliation":[{"name":"Congenital heart surgery, Amosov National Institute of Cardiovascular Surgery , Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliya","family":"Prokopovych","sequence":"additional","affiliation":[{"name":"Congenital heart surgery, Amosov National Institute of Cardiovascular Surgery , Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslav","family":"Truba","sequence":"additional","affiliation":[{"name":"Congenital heart surgery, Amosov National Institute of Cardiovascular Surgery , Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"DiSessa","sequence":"additional","affiliation":[{"name":"University of Kentucky , Lexington, KY, USA"},{"name":"William Novick Global Cardiac Alliance , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4506-6113","authenticated-orcid":false,"given":"William","family":"Novick","sequence":"additional","affiliation":[{"name":"William Novick Global Cardiac Alliance , Memphis, TN, USA"},{"name":"University of Tennessee Health Science Center-Global Surgery Institute , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"2022071110455670500_ezac347-B1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/s1010-7940(05)80004-1.","article-title":"Extracorporeal membrane oxygenation and the treatment of critical pulmonary hypertension in congenital heart disease","volume":"9","author":"Dhillon","year":"1995","journal-title":"European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery"},{"key":"2022071110455670500_ezac347-B2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/hrt.2002.003509","article-title":"Cardiac ECMO for biventricular hearts after paediatric open-heart surgery","volume":"90","author":"Chaturvedi","year":"2004","journal-title":"Heart"},{"key":"2022071110455670500_ezac347-B3","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0003-4975(98)00956-4","article-title":"Double Patch Closure of Ventricular Septal Defect with Increased Pulmonary Vascular Resistance","volume":"66","author":"Novick","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"2022071110455670500_ezac347-B4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.athoracsur.2004.06.107","article-title":"Flap Valve Double Patch Closure of Ventricular Septal Defects in Children with Increased Pulmonary Vascular Resistance","volume":"79","author":"Novick","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"2022071110455670500_ezac347-B5","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.athoracsur.2005.11.050","article-title":"Pulmonary Artery Hypertension: is It Really a Contraindicating Factor for Early Extubation in Children After Cardiac Surgery?","volume":"81","author":"Vida","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"2022071110455670500_ezac347-B6","doi-asserted-by":"crossref","DOI":"10.1016\/j.athoracsur.2021.06.018","article-title":"Sildenafil\u2019s Early, Late Impact on Ventricular Septal Repair: Older Children Using the Double Patch","author":"Novick","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"2022071110455670500_ezac347-B7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.CIR.21.1.13","article-title":"Selection for Surgery of Patients with Ventricular Septal Defect and Pulmonary Hypertension","volume":"31","author":"DuShane","year":"1960","journal-title":"Circulation"},{"key":"2022071110455670500_ezac347-B8","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric Pulmonary Hypertension Guidelines from the American Heart Association and American Thoracic Society","volume":"132","author":"Abman","year":"2015","journal-title":"Circulation"},{"key":"2022071110455670500_ezac347-B9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1136\/heartjnl-2018-314025","article-title":"Assessment of reversibility in pulmonary arterial hypertension and congenital heart disease","volume":"105","author":"van der Feen","year":"2019","journal-title":"Heart"},{"key":"2022071110455670500_ezac347-B10","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.jacc.2020.03.047","article-title":"Challenges and Special Aspects of Pulmonary Hypertension in Middle- to Low-Income Regions","volume":"75","author":"Hasan","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022071110455670500_ezac347-B11","doi-asserted-by":"publisher","first-page":"ii23","DOI":"10.1136\/heartjnl-2014-307340","article-title":"Hemodynamic assessment and acute pulmonary vasoreactivity testing in the evaluation of children with pulmonary vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK","volume":"102","author":"Christian Apitz","year":"2016","journal-title":"Heart"},{"key":"2022071110455670500_ezac347-B12","doi-asserted-by":"publisher","first-page":"ii57","DOI":"10.1136\/heartjnl-2015-307774","article-title":"Pulmonary hypertension in the intensive care unit. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK","volume":"102","author":"Kaestner","year":"2016","journal-title":"Heart"},{"key":"2022071110455670500_ezac347-B13","first-page":"238","article-title":"Sildenafil Therapy for Pulmonary Hypertension Before and After Pediatric Congenital Heart Surgery","volume":"38","author":"Palma","year":"2011","journal-title":"Tex Heart Inst J"},{"key":"2022071110455670500_ezac347-B14","first-page":"1165","article-title":"Midterm results of \u201ctreat and repair\u201d for adults with non-restrictive ventricular septal defect and severe pulmonary hypertension","volume":"7","author":"Hu","year":"2015","journal-title":"J Thorac Dis"},{"key":"2022071110455670500_ezac347-B15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.15171\/jcvtr.2017.31","article-title":"The role of preoperative sildenafil therapy in controlling of postoperative pulmonary hypertension in children with ventricular septal defects","volume":"9","author":"Bigdelian","year":"2017","journal-title":"J Cardiovasc Thorac Res"},{"key":"2022071110455670500_ezac347-B16","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1111\/jocs.15030","article-title":"Benefits of perioperative sildenafil therapy in children with a ventricular septal defect with pulmonary artery hypertension on early surgical outcomes","volume":"35","author":"Patel","year":"2020","journal-title":"J Card Surg"},{"key":"2022071110455670500_ezac347-B17","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/eurheartj\/eht437","article-title":"Pulmonary hypertension related to congenital heart disease: a call for action","volume":"35","author":"Dimopoulos","year":"2014","journal-title":"Eur Heart J"},{"key":"2022071110455670500_ezac347-B18","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2013.07.099","article-title":"Building Quality Indicators to Improve Care for Adults with Congenital Heart Disease","volume":"62","author":"Gurvitz","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022071110455670500_ezac347-B19","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.jtcvs.2020.05.084","article-title":"Global health initiatives in cardiothoracic surgery: ethical considerations and guidelines","volume":"161","author":"Fenton","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2022071110455670500_ezac347-B20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpeds.2018.09.067","article-title":"Sildenafil Use in Children with Pulmonary Hypertension","volume":"205","author":"Cohen","year":"2019","journal-title":"J Pediatr"},{"key":"2022071110455670500_ezac347-B21","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/CIRCULATIONAHA.113.005698","article-title":"STARTS-2 Long-Term Survival with Oral Sildenafil Monotherapy in Treatment-Naive Pediatric Pulmonary Arterial Hypertension","volume":"129","author":"Barst","year":"2014","journal-title":"Circulation"},{"key":"2022071110455670500_ezac347-B22","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1017\/S1047951117000981","article-title":"Comparison of the therapeutic effects and side effects of tadalafil and sildenafil after surgery in young infants with pulmonary arterial hypertension due to systemic-to-pulmonary shunts","volume":"27","author":"Sabri","year":"2017","journal-title":"Cardiol Young"},{"key":"2022071110455670500_ezac347-B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2045894019837885","article-title":"Parameters associated with outcome in pediatric patients with congenital heart disease and pulmonary hypertension subjected to combined vasodilator and surgical treatments","volume":"9","author":"Thomaz","year":"2019","journal-title":"Pulm Circ"},{"key":"2022071110455670500_ezac347-B24","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N Engl J Med"},{"key":"2022071110455670500_ezac347-B25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCULATIONAHA.110.016667","article-title":"A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children with Pulmonary Arterial Hypertension","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"key":"2022071110455670500_ezac347-B26","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1093\/ejcts\/ezv353","article-title":"Preoperative Sildenafil administration in children undergoing cardiac surgery: a randomized controlled preconditioning study","volume":"49","author":"Walavalkar","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2022071110455670500_ezac347-B27","first-page":"19","article-title":"Additive Effect of Phosphodiesterase Inhibitors in Control of Pulmonary Hypertension after Congenital Cardiac Surgery in Children","volume":"23","author":"Peiravian","year":"2013","journal-title":"Iran J Pediatr"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezac347\/44281774\/ezac347.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/62\/2\/ezac347\/44818024\/ezac347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/62\/2\/ezac347\/44818024\/ezac347.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T10:46:13Z","timestamp":1657536373000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/doi\/10.1093\/ejcts\/ezac347\/6619555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,7,11]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezac347","relation":{},"ISSN":["1873-734X"],"issn-type":[{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2022,6,29]]},"article-number":"ezac347"}}